Sunshine Biopharma (SBFM) Short-term Investments (2019 - 2025)

Sunshine Biopharma's Short-term Investments history runs 5 years deep, the most recent figure standing at $70457.0 for Q1 2025.

• Quarterly Short-term Investments changed N/A year-over-year to $70457.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $70457.0 (changed N/A YoY) and the FY2021 annual result came in at $7590.0, changed 0.0% from the prior year.
• Short-term Investments was $70457.0 for Q1 2025 at Sunshine Biopharma, up from $7590.0 in the prior quarter.
• Across five years, Short-term Investments topped out at $70457.0 in Q1 2025 and bottomed at $7590.0 in Q1 2021.
• A 3-year average of $15448.4 and a median of $7590.0 in 2021 frame the typical range for Short-term Investments.
• Peak annual rise in Short-term Investments reached 0.0% in 2021, while the deepest fall reached 0.0% in 2021.
• Sunshine Biopharma's Short-term Investments stood at $7590.0 in 2021, then changed by 0.0% to $7590.0 in 2022, then soared by 828.29% to $70457.0 in 2025.
• Business Quant data shows SBFM's Short-term Investments at $70457.0 in Q1 2025, $7590.0 in Q3 2022, and $7590.0 in Q2 2022.